1583. A Case Series of Low-Level HBV Viremia After Switching to Long-Acting Injectable Cabotegravir/Rilpivirine in Patients with HIV, Hepatitis B Core Antibody Positivity, and Hepatitis B Surface Antigen Negativity

BACKGROUND: Two-drug antiretroviral therapy (ART), including long-acting injectable cabotegravir and rilpivirine (LAI CAB/RPV), is increasingly used for treatment of people with HIV. Many two-drug regimens do not contain tenofovir (TFV), and guidelines recommend ensuring patients are not chronically...

Descripción completa

Detalles Bibliográficos
Autores principales: Welford, Elliott, Yin, Jeffrey, Hill, Lucas, Wooten, Darcy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751910/
http://dx.doi.org/10.1093/ofid/ofac492.106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751910/
http://dx.doi.org/10.1093/ofid/ofac492.106

Ejemplares similares